As is true for all three PPARs, non-genomic plasma membrane receptors for physiological free fatty acids and the glitazone class of synthetic PPARγ agonists have been validated to rapidly transduce signals towards the cell interior and activate MAPK signaling, proliferation and survival of cancer cells [142]. The gene discussed is PPARG; the disease is cancer.